New York, NY (December 10, 2022) — A new therapy that forces the immune system to kill bone marrow cancer cells has been successful in up to 73% of patients in two clinical trials, according to researchers from the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. The therapy, known as …
Experimental Cancer Therapy Shows Over 70% Patient Success in Global Clinical Trials Read More »
Elon Musk’s recent Twitter buying and love of free speech has sparked a storm of conversations about mental health issues related to hate speech and bullying. Calls for cancellation, removal from the platform, content throttling and other stifling measures are often made in the name of “trust and safety”. But these conversations rarely consider the …
NEW ORLEANS – In addition to news about the latest in clinical care and drug development, some startling discoveries that challenge long-held but untested assumptions are promised at the annual meeting of the American Society of Hematology. The conference begins in New Orleans on Saturday, but a sample of what’s to come was given last …
ASH 2022: Longstanding new assumptions about the clinical data challenge Read More »
1. In patients with end-stage ankle osteoarthritis, no difference was observed in outcomes between total ankle replacement (TAR) and ankle fusion (AF) surgeries. 2. There were no significant differences in the rate of adverse events in patients who received ART compared to AF surgeries. Level of evidence assessment: 1 (Excellent) Summary of the study: Surgical …
Premise Health is one of the nation’s largest direct healthcare providers. His approach emphasizes clinical expertise, easy access to care and a smooth and simple patient experience. Premise has a network of over 800 wellness centers in 45 states and Guam. Premise’s physicians, nurse practitioners, pharmacists, physical therapists and other providers deliver care in person …
Published Medicine, Inc. CAMBRIDGE, Mass., Dec. 01 10, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it will host a live webinar on Tuesday, December 6, at 8:00 a.m. ET to present initial clinical data from the RUBY Phase 1/2 trial of EDIT-301, being developed for …
CNN — An experimental HIV vaccine has been shown to induce largely neutralizing antibodies in a small group of volunteers in a phase 1 study. The results suggest that a two-dose regimen of the vaccine, given eight weeks apart, can induce immune responses against the human immunodeficiency virus. The results of the clinical trial, published …
Almirall brings experience in privacy and pharmaceutical law, as well as in developing guidance, standards and recommendations for communicating clinical trial data to patients The project will last four years and will involve 27 partners from 16 EU and extra-EU Member States, including patient organisations, hospitals, universities, SMEs and members of the European Federation of …
Barcelona, Spain–(BUSINESS WIRE)–Almirall, SA (ALM)a global biopharmaceutical company focused on skin health, today announced its participation in FACILITATE(FrAwork for VSIINicholasL trIon the day of the participantsBY reuse for full use Jtransparent and Eethical ecosystem) a patient-focused project of the Innovative Medicines Initiative (IMI) aimed at create a framework for access and reuse of clinical trial …
The University of Michigan Faculty Senate met Monday in the University Lobby of the Alexander G. Ruthven Building to discuss the possibility of partially restructuring the Senate Assembly. The Faculty Senate currently consists of more than 4,250 members from UM’s three campuses – all tenure-track faculty, research faculty, librarians, senior staff, and deans are members. …
The UMich Senate Assembly can add clinical professors and lecturers Read More »
